Girmenia Corrado, Martino Pietro
Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome, Italy.
Semin Respir Crit Care Med. 2005 Oct;26(5):445-57. doi: 10.1055/s-2005-922029.
Pulmonary infections are second in importance only to septicemia as a cause of infectious morbidity and mortality in patients with hematological disorders. The differential diagnosis of the pneumonitis syndrome includes not only infection but also a multitude of noninfectious causes. In addition, the diagnosis may be difficult, owing to the subtlety of the clinical signs as a consequence of the impaired inflammatory response. Radiographic findings are often nonspecific, and invasive procedures and microbiological exams are required to establish the cause of pulmonary disease and to choose a specific therapy. However, invasive diagnostic procedures are often precluded by the poor general conditions and (particularly in acute leukemia patients) by concurrent thrombocytopenia. The approach to all infectious complications, including those of the lower respiratory tract, in immunocompromised patients with hematological diseases, is based on aggressive prevention strategies and the empirical administration of broad-spectrum antimicrobials eventually followed by a clinically or microbiologically guided treatment modification. With regard to the antimicrobial treatment, given the variety of infectious and noninfectious causes of pulmonary infiltrates in patients with hematological diseases, the diversity of the underlying immunocompromised state, and the spectrum of clinical findings, no single general therapeutic algorithm can be applied.
肺部感染在血液系统疾病患者的感染性发病率和死亡率原因中仅次于败血症。肺炎综合征的鉴别诊断不仅包括感染,还包括多种非感染性原因。此外,由于炎症反应受损导致临床体征不明显,诊断可能会很困难。影像学表现通常不具有特异性,需要进行侵入性检查和微生物学检查来确定肺部疾病的病因并选择特定的治疗方法。然而,一般状况较差以及(特别是在急性白血病患者中)并发血小板减少症常常使侵入性诊断程序无法进行。对于血液系统疾病免疫功能低下患者的所有感染并发症,包括下呼吸道感染并发症,治疗方法基于积极的预防策略以及经验性使用广谱抗菌药物,最终根据临床或微生物学指导调整治疗方案。关于抗菌治疗,鉴于血液系统疾病患者肺部浸润的感染性和非感染性原因多种多样、潜在免疫功能低下状态各不相同以及临床表现范围广泛,无法应用单一的通用治疗方案。